{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:49Z","timestamp":1791378169741,"version":"4.3.2"},"reference-count":25,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"WINMEDICA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Pharmacologic cardioversion is a well-established alternative to electric cardioversion for hemodynamically stable patients, as it skips the risks associated with anesthesia. A recent network meta-analysis identifies the most effective antiarrhythmics for pharmacologic cardioversion with flecainide exhibiting a more efficacious and safer profile towards faster cardioversion. Moreover, the meta-analysis of class Ic antiarrhythmics revealed an absence of adverse events when used for pharmacologic cardioversion of AF in the ED, including patients with structural heart disease. The primary goals of this clinical trial are to prove the superiority of flecainide over amiodarone in the successful cardioversion of paroxysmal atrial fibrillation in the Emergency Department and to prove that the safety of flecainide is non-inferior to amiodarone in patients with coronary artery disease without residual ischemia, and an ejection fraction over 35%. The secondary goals of this study are to prove the superiority of flecainide over amiodarone in the reduction in hospitalizations from the Emergency Department due to atrial fibrillation in the time taken to achieve cardioversion, and in the reduction in the need to conduct electrical cardioversion.<\/jats:p>","DOI":"10.3390\/jcm12123961","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T01:59:07Z","timestamp":1686535147000},"page":"3961","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rationale and Design of a Randomized Controlled Clinical Trial on the Safety and Efficacy of Flecainide versus Amiodarone in the Cardioversion of Atrial Fibrillation at the Emergency Department in Patients with Coronary Artery Disease (FLECA-ED)"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-7430","authenticated-orcid":false,"given":"Panagiotis","family":"Tsioufis","sequence":"first","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-9712","authenticated-orcid":false,"given":"Dimitris","family":"Tsiachris","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Athens Heart Center, Athens Medical Center, 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-3296","authenticated-orcid":false,"given":"Ioannis","family":"Doundoulakis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Athens Heart Center, Athens Medical Center, 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Kordalis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-2404","authenticated-orcid":false,"given":"Christos-Konstantinos","family":"Antoniou","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Athens Heart Center, Athens Medical Center, 11526 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-4942","authenticated-orcid":false,"given":"Panayotis K.","family":"Vlachakis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":false,"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Manta","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[{"name":"Emergency Department, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide Epidemiology of Atrial Fibrillation","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ajem.2016.07.023","article-title":"Hospital-Level Variation and Predictors of Admission after ED Visits for Atrial Fibrillation: 2006 to 2011","volume":"34","author":"Lin","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.amjcard.2017.08.017","article-title":"Emergency Department, Hospital Inpatient, and Mortality Burden of Atrial Fibrillation in the United States, 2006 to 2014","volume":"120","author":"Jackson","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e009024","DOI":"10.1161\/JAHA.118.009024","article-title":"Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014","volume":"7","author":"Rozen","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","article-title":"Contemporary Trends of Hospitalization for Atrial Fibrillation in the United States, 2000 through 2010","volume":"129","author":"Patel","year":"2014","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e002984","DOI":"10.1161\/JAHA.115.002984","article-title":"Impact of an Emergency Department Observation Unit Management Algorithm for Atrial Fibrillation","volume":"5","author":"Bellew","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5811\/westjem.2012.1.6893","article-title":"Impact of Emergency Department Management of Atrial Fibrillation on Hospital Charges","volume":"14","author":"Sacchetti","year":"2013","journal-title":"West. J. Emerg. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.annemergmed.2011.06.014","article-title":"Is Discharge to Home After Emergency Department Cardioversion Safe for the Treatment of Recent-Onset Atrial Fibrillation?","volume":"58","author":"Mills","year":"2011","journal-title":"Ann. Emerg. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/acem.13703","article-title":"Benefits of Rhythm Control and Rate Control in Recent-onset Atrial Fibrillation: The HERMES-AF Study","volume":"26","author":"Suero","year":"2019","journal-title":"Acad. Emerg. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjcard.2013.02.056","article-title":"Predictors of Progression of Recently Diagnosed Atrial Fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)\u2013United States Cohort","volume":"112","author":"Zhang","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The Impact of Atrial Fibrillation Type on the Risk of Thromboembolism, Mortality, and Bleeding: A Systematic Review and Meta-Analysis","volume":"37","author":"Ganesan","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_12","first-page":"230","article-title":"Management of Atrial Fibrillation in the Emergency Room and in the Cardiology Ward: The BLITZ AF Study","volume":"21","author":"Gulizia","year":"2018","journal-title":"EP Eur."},{"key":"ref_13","first-page":"ehaa612","article-title":"2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_14","first-page":"1609","article-title":"2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"EP Eur."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000526831","article-title":"Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study","volume":"147","author":"Bager","year":"2022","journal-title":"Cardiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00228-022-03296-0","article-title":"Reappraising the Role of Class Ic Antiarrhythmics in Atrial Fibrillation","volume":"78","author":"Tsiachris","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_18","first-page":"1200","article-title":"Single-Dose Oral Anti-Arrhythmic Drugs for Cardioversion of Recent-Onset Atrial Fibrillation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","volume":"23","author":"Ibrahim","year":"2020","journal-title":"EP Eur."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10557-020-07127-1","article-title":"Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis","volume":"35","author":"Tsiachris","year":"2021","journal-title":"Cardiovasc. Drug. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annemergmed.2020.01.013","article-title":"Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department: A Systematic Review and Network Meta-Analysis","volume":"76","author":"deSouza","year":"2019","journal-title":"Ann. Emerg. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1161\/01.CIR.90.6.2843","article-title":"Interaction of Baseline Characteristics with the Hazard of Encainide, Flecainide, and Moricizine Therapy in Patients with Myocardial Infarction. A Possible Explanation for Increased Mortality in the Cardiac Arrhythmia Suppression Trial (CAST)","volume":"90","author":"Anderson","year":"2018","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0002-9149(91)90308-8","article-title":"Increased Risk of Death and Cardiac Arrest from Encainide and Flecainide in Patients after Non-Q-Wave Acute Myocardial Infarction in the Cardiac Arrhythmia Suppression Trial","volume":"68","author":"Akiyama","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0002-9149(02)02867-9","article-title":"Efficacy and Safety of Propafenone Sustained Release in the Prophylaxis of Symptomatic Paroxysmal Atrial Fibrillation (The European Rythmol\/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)","volume":"90","author":"Meinertz","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kiani, S., Sayegh, M.N., Ibraham, R., Bhatia, N.K., Merchant, F.M., Shah, A.D., Westerman, S.B., Lurgio, D.B.D., Patel, A.M., and Thompkins, C.M. (2023). The Feasibility and Safety of Flecainide Use Among Patients with Varying Degrees of Coronary Disease. JACC Clin. Electrophysiol., in press.","DOI":"10.1016\/j.jacep.2022.12.021"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/12\/3961\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:52:15Z","timestamp":1760125935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/12\/3961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["jcm12123961"],"URL":"https:\/\/doi.org\/10.3390\/jcm12123961","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]}}}